MarketScreener Editorial Features Nile Therapeutics, Inc. Other OTC
Equities
US6541451018
End-of-day quote
Other stock markets
|
||
- USD | - |
05-13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
05-13 | Earnings Flash (CAPR) CAPRICOR THERAPEUTICS Posts Q1 Revenue $4.9M, vs. Street Est of $9.7M | MT |
- Stock Market
- Equities
- CAPR Stock
- Stock
- News Nile Therapeutics, Inc.
- MarketScreener Editorial Features